Compositions for treating muscular dystrophy

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9506058
APP PUB NO 20140315862A1
SERIAL NO

14214567

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Improved compositions and methods for treating muscular dystrophy by administering antisense molecules capable of binding to a selected target site in the human dystrophin gene to induce exon skipping are described.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
BIOPHARMA CREDIT PLC51 NEW NORTH ROAD C/O BEAUFORT HOUSE EXETER EX4 4EP

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Kaye, Edward M Cambridge, US 12 308

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 29, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00